SOURCE: annual_report_text (1).txt
CHUNK: 87 of 1106
SIZE: 601 characters
PREVIOUS: chunk_0086_annual_report_text (1).txt
NEXT: chunk_0088_annual_report_text (1).txt
------------------------------
RAPY CENTERS AT END OF 
2023 LARGEST NETWORK & EXPERIENCE
IBA continued to strengthen its market leadership in 2023 with 
the sale of several proton therapy systems: two ProteusONE 
systems to be delivered at the Sourasky Medical Center 
in Tel Aviv, Israel, one ProteusONE equipment to be supplied 
to the Wielkopolskie Centrum Onkologii in Poznan, Poland 
and a ProteusPLUS system to be supplied by IBAs Partner CGN 
to the West China Hospital in Chengdu, China. 34 ProteusPLUS Centers
41 ProteusONE Centers
Market share in rooms (end 2023)
ProteusONE and ProteusPLUS are brand names of Proteus 235.